Content deleted Content added
Removing disambig link |
m →Medical-related terms: added parenthetical comma |
||
Line 30:
=== Medical-related terms ===
It is important to note that most transgender individuals will receive few, if any, surgeries throughout their lifetimes and some may never receive HRT. Barriers to accessing medical transitioning can include: a lack of financing, a lack of desire, or a lack of accessibility. There is no one way to transition, and while a medical transition or surgery can absolutely be medically necessary for some individuals' personal wellbeing, no two transitions are the same.
* [[Puberty blockers|'''Puberty blockers / hormone blockers''']] are terms that refer to medications used to block natal sex hormones. For transgender youth, hormone blockers may be offered at the onset of puberty to allow the exploration of their gender identity without the distress<ref name=":7">{{Cite journal |last1=Turban |first1=Jack L. |last2=King |first2=Dana |last3=Carswell |first3=Jeremi M. |last4=Keuroghlian |first4=Alex S. |date=1 February 2020 |title=Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation |url=https://publications.aap.org/pediatrics/article/145/2/e20191725/68259/Pubertal-Suppression-for-Transgender-Youth-and?autologincheck=redirected |pmid=31974216 |access-date=2024-07-21 |journal=Pediatrics|volume=145 |issue=2 |doi=10.1542/peds.2019-1725 |pmc=7073269 }}</ref><ref name=":8">{{Cite journal |last=Lambrese |first=Jason |date=2010-08-01 |title=Suppression of Puberty in Transgender Children |url=https://journalofethics.ama-assn.org/article/suppression-puberty-transgender-children/2010-08 |journal=AMA Journal of Ethics |language=en |volume=12 |issue=8 |pages=645–649 |doi=10.1001/virtualmentor.2010.12.8.jdsc1-1008 |issn=2376-6980 |pmid=23186849}}</ref> of [[Puberty|irreversible pubertal changes]]. Puberty blockers are considered reversible<ref name=":2">{{Cite journal |last1=Rölver |first1=Angela |last2=Föcker |first2=Manuel |last3=Romer |first3=Georg |date=2022 |title=Desisting from gender dysphoria after 1,5 years of puberty suppression: A case report |department=Department of Child and Adolescent Psychiatry |journal=University Hospital Münster |volume=1 |issue=2 |doi=10.1016/j.psycr.2022.100049|doi-access=free }}</ref> and their use is deemed safe and effective<ref>{{Cite journal |last1=Rew |first1=Lynn |last2=Young |first2=Cara C. |last3=Monge |first3=Maria |last4=Bogucka |first4=Roxanne |date=February 2021 |title=Review: Puberty blockers for transgender and gender diverse youth—a critical review of the literature |url=https://acamh.onlinelibrary.wiley.com/doi/10.1111/camh.12437 |journal=Child and Adolescent Mental Health |language=en |volume=26 |issue=1 |pages=3–14 |doi=10.1111/camh.12437 |issn=1475-357X |pmid=33320999}}</ref> as treatment for gender dysphoria in gender-diverse children<ref>{{Cite journal |last1=Giordano |first1=Simona |last2=Holm |first2=Søren |date=2020-04-02 |title=Is puberty delaying treatment 'experimental treatment'? |journal=International Journal of Transgender Health |language=en |volume=21 |issue=2 |pages=113–121 |doi=10.1080/26895269.2020.1747768 |issn=2689-5269 |pmc=7430465 |pmid=33015663}}</ref> and [[precocious puberty]] in [[cisgender]] children;<ref>{{Cite journal |last=Eugster |first=Erica A |date=May 2019 |title=Treatment of Central Precocious Puberty |journal=Journal of the Endocrine Society |volume=3 |issue=5 |pages=965–972 |doi=10.1210/js.2019-00036 |pmc=6486823 |pmid=31041427}}</ref> their use may be discontinued at any time if natal puberty-blocking is no longer desired.<ref name=":2" /> For transgender adults, hormone blockers may be offered in a course with cross-sex hormone replacement therapy in order to treat gender dysphoria.
| |||